Alf Meem Yaa for Medical Supplies and Equipment Company - 9527.SR - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	90	122	151	193	223	248	305	209	📊
Revenue Growth (1Y)	--	+35.23%	+24.49%	+27.60%	+15.61%	+11.21%	+22.80%	-31.60%	📊
Revenue Growth (5Y)	--	--	--	--	+148.35%	+104.23%	+101.45%	+37.80%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	48	67	82	103	125	148	176	127	📊
Cost of Revenue Growth (1Y)	--	+38.02%	+22.86%	+25.72%	+21.07%	+18.83%	+19.23%	-28.28%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+158.10%	+122.19%	+115.63%	+54.65%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	42	55	70	90	99	100	128	82	📊
Gross Profit Growth (1Y)	--	+32.00%	+26.47%	+29.82%	+9.38%	+1.60%	+28.06%	-36.15%	📊
Gross Profit Growth (5Y)	--	--	--	--	+137.06%	+82.47%	+84.75%	+17.97%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	25	32	45	60	61	51	86	12	📊
Operating Expenses Growth (1Y)	--	+27.85%	+38.99%	+33.92%	+1.92%	-16.99%	+67.73%	-85.91%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+142.56%	+57.49%	+90.06%	-73.22%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	25	32	28	36	61	55	0	7	📊
Research and Development	0	0	0	0	0	0	0	--	📊
Other Income Expenses	0	0	0	0	0	4	86	6	📊
EBITDA	16	23	25	31	40	52	43	71	📊
EBITDA Growth (1Y)	--	+39.31%	+8.55%	+24.77%	+28.34%	+30.84%	-17.56%	+64.89%	📊
EBITDA Growth (5Y)	--	--	--	--	+142.14%	+127.43%	+72.73%	+184.82%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	1	2	2	0	--	📊
Operating Income	16	23	25	30	37	49	43	70	📊
Operating Income Growth (1Y)	--	+38.44%	+8.52%	+22.28%	+24.39%	+32.25%	-12.99%	+63.13%	📊
Operating Income Growth (5Y)	--	--	--	--	+128.52%	+118.28%	+75.01%	+185.49%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	1	0	0	1	📊
Pre Tax Income	16	23	24	30	38	50	0	11	📊
Tax Provision	2	2	3	3	4	5	0	1	📊
NET INCOME	15	21	21	27	34	45	35	17	📊
Net Income Growth (1Y)	--	+42.27%	+0.72%	+25.73%	+25.60%	+35.46%	-22.89%	-51.35%	📊
Net Income Growth (5Y)	--	--	--	--	+126.29%	+115.46%	+64.96%	-19.75%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	2.12	3.01	3.05	3.81	4.79	6.49	5	2.43	📊
Diluted EPS	2.12	3.01	3.05	3.81	4.79	0	5	2.43	📊
Basic Average Shares	7	7	7	7	7	7	7	7	📊
Diluted Average Shares	7	7	7	7	7	7	7	7	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

122

151

193

223

248

305

209

📊

Revenue Growth (1Y)

+35.23%

+24.49%

+27.60%

+15.61%

+11.21%

+22.80%

-31.60%

📊

Revenue Growth (5Y)

+148.35%

+104.23%

+101.45%

+37.80%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

103

125

148

176

127

📊

Cost of Revenue Growth (1Y)

+38.02%

+22.86%

+25.72%

+21.07%

+18.83%

+19.23%

-28.28%

📊

Cost of Revenue Growth (5Y)

+158.10%

+122.19%

+115.63%

+54.65%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

100

128

📊

Gross Profit Growth (1Y)

+32.00%

+26.47%

+29.82%

+9.38%

+1.60%

+28.06%

-36.15%

📊

Gross Profit Growth (5Y)

+137.06%

+82.47%

+84.75%

+17.97%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+27.85%

+38.99%

+33.92%

+1.92%

-16.99%

+67.73%

-85.91%

📊

Operating Expenses Growth (5Y)

+142.56%

+57.49%

+90.06%

-73.22%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

📊

EBITDA

📊

EBITDA Growth (1Y)

+39.31%

+8.55%

+24.77%

+28.34%

+30.84%

-17.56%

+64.89%

📊

EBITDA Growth (5Y)

+142.14%

+127.43%

+72.73%

+184.82%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

📊

Operating Income Growth (1Y)

+38.44%

+8.52%

+22.28%

+24.39%

+32.25%

-12.99%

+63.13%

📊

Operating Income Growth (5Y)

+128.52%

+118.28%

+75.01%

+185.49%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

📊

Tax Provision

📊

NET INCOME

📊

Net Income Growth (1Y)

+42.27%

+0.72%

+25.73%

+25.60%

+35.46%

-22.89%

-51.35%

📊

Net Income Growth (5Y)

+126.29%

+115.46%

+64.96%

-19.75%

📊

Net Income Growth (10Y)

📊

Basic EPS

2.12

3.01

3.05

3.81

4.79

6.49

2.43

📊

Diluted EPS

2.12

3.01

3.05

3.81

4.79

2.43

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	90	122	151	193	223	248	305	209	📊
Revenue Growth (1Y)	--	+35.23%	+24.49%	+27.60%	+15.61%	+11.21%	+22.80%	-31.60%	📊
Revenue Growth (5Y)	--	--	--	--	+148.35%	+104.23%	+101.45%	+37.80%	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	48	67	82	103	125	148	176	127	📊
Cost of Revenue Growth (1Y)	--	+38.02%	+22.86%	+25.72%	+21.07%	+18.83%	+19.23%	-28.28%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+158.10%	+122.19%	+115.63%	+54.65%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	42	55	70	90	99	100	128	82	📊
Gross Profit Growth (1Y)	--	+32.00%	+26.47%	+29.82%	+9.38%	+1.60%	+28.06%	-36.15%	📊
Gross Profit Growth (5Y)	--	--	--	--	+137.06%	+82.47%	+84.75%	+17.97%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	25	32	45	60	61	51	86	12	📊
Operating Expenses Growth (1Y)	--	+27.85%	+38.99%	+33.92%	+1.92%	-16.99%	+67.73%	-85.91%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+142.56%	+57.49%	+90.06%	-73.22%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	25	32	28	36	61	55	0	7	📊
Research and Development	0	0	0	0	0	0	0	--	📊
Other Income Expenses	0	0	0	0	0	4	86	6	📊
EBITDA	16	23	25	31	40	52	43	71	📊
EBITDA Growth (1Y)	--	+39.31%	+8.55%	+24.77%	+28.34%	+30.84%	-17.56%	+64.89%	📊
EBITDA Growth (5Y)	--	--	--	--	+142.14%	+127.43%	+72.73%	+184.82%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	0	0	1	2	2	0	--	📊
Operating Income	16	23	25	30	37	49	43	70	📊
Operating Income Growth (1Y)	--	+38.44%	+8.52%	+22.28%	+24.39%	+32.25%	-12.99%	+63.13%	📊
Operating Income Growth (5Y)	--	--	--	--	+128.52%	+118.28%	+75.01%	+185.49%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	1	0	0	1	📊
Pre Tax Income	16	23	24	30	38	50	0	11	📊
Tax Provision	2	2	3	3	4	5	0	1	📊
NET INCOME	15	21	21	27	34	45	35	17	📊
Net Income Growth (1Y)	--	+42.27%	+0.72%	+25.73%	+25.60%	+35.46%	-22.89%	-51.35%	📊
Net Income Growth (5Y)	--	--	--	--	+126.29%	+115.46%	+64.96%	-19.75%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	2.12	3.01	3.05	3.81	4.79	6.49	5	2.43	📊
Diluted EPS	2.12	3.01	3.05	3.81	4.79	0	5	2.43	📊
Basic Average Shares	7	7	7	7	7	7	7	7	📊
Diluted Average Shares	7	7	7	7	7	7	7	7	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

122

151

193

223

248

305

209

📊

Revenue Growth (1Y)

+35.23%

+24.49%

+27.60%

+15.61%

+11.21%

+22.80%

-31.60%

📊

Revenue Growth (5Y)

+148.35%

+104.23%

+101.45%

+37.80%

📊

Revenue Growth (10Y)

📊

Cost of Revenue

103

125

148

176

127

📊

Cost of Revenue Growth (1Y)

+38.02%

+22.86%

+25.72%

+21.07%

+18.83%

+19.23%

-28.28%

📊

Cost of Revenue Growth (5Y)

+158.10%

+122.19%

+115.63%

+54.65%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

100

128

📊

Gross Profit Growth (1Y)

+32.00%

+26.47%

+29.82%

+9.38%

+1.60%

+28.06%

-36.15%

📊

Gross Profit Growth (5Y)

+137.06%

+82.47%

+84.75%

+17.97%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+27.85%

+38.99%

+33.92%

+1.92%

-16.99%

+67.73%

-85.91%

📊

Operating Expenses Growth (5Y)

+142.56%

+57.49%

+90.06%

-73.22%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

📊

EBITDA

📊

EBITDA Growth (1Y)

+39.31%

+8.55%

+24.77%

+28.34%

+30.84%

-17.56%

+64.89%

📊

EBITDA Growth (5Y)

+142.14%

+127.43%

+72.73%

+184.82%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

📊

Operating Income Growth (1Y)

+38.44%

+8.52%

+22.28%

+24.39%

+32.25%

-12.99%

+63.13%

📊

Operating Income Growth (5Y)

+128.52%

+118.28%

+75.01%

+185.49%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

📊

Tax Provision

📊

NET INCOME

📊

Net Income Growth (1Y)

+42.27%

+0.72%

+25.73%

+25.60%

+35.46%

-22.89%

-51.35%

📊

Net Income Growth (5Y)

+126.29%

+115.46%

+64.96%

-19.75%

📊

Net Income Growth (10Y)

📊

Basic EPS

2.12

3.01

3.05

3.81

4.79

6.49

2.43

📊

Diluted EPS

2.12

3.01

3.05

3.81

4.79

2.43

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date
Payment date
Annual Dividend	2.00 (SAR)
Dividend Yield	3.15%
Shareholders Yield	--
Next Earnings	--
Market cap	443.80M (SAR)
EPS (TTM)	2.43 (SAR)
P/E (TTM)	26.09 (SAR)
Last Close	63.40

Next Earnings	--
Market cap	443.80M (SAR)
EPS (TTM)	2.43 (SAR)
P/E (TTM)	26.09 (SAR)
Last Close	63.40 (SAR)

Ex-Dividend date
Payment date
Annual Dividend	2.00 (SAR)
Dividend Yield	3.15%
Shareholders Yield	--
Next Earnings	--
Market cap	443.80M (SAR)
EPS (TTM)	2.43 (SAR)
P/E (TTM)	26.09 (SAR)
Last Close	63.40

Next Earnings	--
Market cap	443.80M (SAR)
EPS (TTM)	2.43 (SAR)
P/E (TTM)	26.09 (SAR)
Last Close	63.40 (SAR)